Definition/General

Introduction: A fibroadenoma with blunt duct adenosis is a fibroadenoma that contains foci of blunt duct adenosis within its epithelial component.
Origin: The blunt duct adenosis arises from the epithelial component of the fibroadenoma.
Classification: It is a subtype of complex fibroadenoma.
Epidemiology: It is a common finding.

Clinical Features

Presentation: Presents as a painless, firm, mobile, well-circumscribed, rubbery mass, similar to a simple fibroadenoma.
Symptoms: A painless, mobile lump is the most common symptom.
Risk Factors: There are no well-established risk factors.
Screening: On mammography, they appear as a well-circumscribed, oval mass.

Master Fibroadenoma with Blunt Duct Adenosis Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-A well-circumscribed, encapsulated, firm, gray-white mass.
Characteristics: The gross appearance is indistinguishable from a simple fibroadenoma.
Size Location: Size is variable.
Multifocality: Can be multiple.

Microscopic Description

Histological Features:
-The lesion is a fibroadenoma with a focus of blunt duct adenosis
-The blunt duct adenosis is characterized by a proliferation of small glands with open lumina, without stromal sclerosis.
Cellular Characteristics: The cytological features are those of blunt duct adenosis.
Architectural Patterns: The background is that of a fibroadenoma.
Grading Criteria: This is a benign lesion.

Immunohistochemistry

Positive Markers: The myoepithelial layer in the blunt duct adenosis component can be highlighted by myoepithelial markers.
Negative Markers: Not typically required for diagnosis.
Diagnostic Utility: IHC is not usually necessary for diagnosis.
Molecular Subtypes: Molecular subtyping is not relevant for this benign condition.

Molecular/Genetic

Genetic Mutations: Not well characterized.
Molecular Markers: No specific molecular markers are routinely used for diagnosis.
Prognostic Significance: A fibroadenoma with blunt duct adenosis is not associated with a significantly increased risk of breast cancer.
Therapeutic Targets: No specific treatment is required.

Differential Diagnosis

Similar Entities: Fibroadenoma with other forms of adenosis.
Distinguishing Features: The features are those of blunt duct adenosis.
Diagnostic Challenges: The main challenge is to correctly identify the type of adenosis.
Rare Variants: There are no specific rare variants.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type], measuring [size] cm in greatest dimension

Diagnosis

[diagnosis name]

Classification

Classification: [classification system] [grade/type]

Histological Features

Shows [architectural pattern] with [nuclear features] and [mitotic activity]

Size and Extent

Size: [X] cm, extent: [local/regional/metastatic]

Margins

Margins are [involved/uninvolved] with closest margin [X] mm

Lymphovascular Invasion

Lymphovascular invasion: [present/absent]

Lymph Node Status

Lymph nodes: [X] positive out of [X] examined

Special Studies

IHC: [marker]: [result]

Molecular: [test]: [result]

[other study]: [result]

Final Diagnosis

Final diagnosis: [complete diagnosis]